Kairos Pharma (KAPA) Change in Cash (2023 - 2025)

Kairos Pharma (KAPA) has 3 years of Change in Cash data on file, last reported at -$582000.0 in Q2 2025.

• Quarterly Change in Cash fell 2963.16% year-over-year to -$582000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $3.0 million (changed N/A YoY) and the FY2025 annual result came in at $3.2 million, up 173.03% from the prior year.
• Change in Cash eased to -$582000.0 in Q2 2025, from $2.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $3.2 million in Q3 2024 to a low of -$1.9 million in Q4 2024.
• A 3-year average of $419285.7 and a median of -$19000.0 in 2024 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2024 — Change in Cash sank 32316.67% — and 2025, when it jumped 4522.64%.
• Tracing KAPA's Change in Cash over 3 years: stood at -$6000.0 in 2023, then slumped by 32316.67% to -$1.9 million in 2024, then soared by 70.08% to -$582000.0 in 2025.
• The last three Change in Cash figures came in at -$582000.0 (Q2 2025), $2.3 million (Q1 2025), and -$1.9 million (Q4 2024), per Business Quant data.